Genespire S.r.l.

https://www.genespire.com

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners. *

	Start	2020-03-01 established (s-off)
	Predecessor	San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET)
	Industry	gene therapy
	Person	Berretta, Julia (Epsilen Bio 202006– CEO + Genespire 202004– CEO before Cellectis 2014–201812 VP BusDev)
	Person 2	Naldini, Luigi (San Raffaele 201909 Director of SR-TIGET + Genenta Co-Founder)

	Region	Milano (Milan)
	Country	Italy
	Street	8 Via Vincenzo Gioberti
	City	20123 Milano
	Tel	+39-02-83991300
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Genespire S.r.l.. (4/29/20). "Press Release: Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies. Biotech Executive, Julia Berretta, Ph.D., Is Named Chief Executive Officer". Milan.

		Record changed: 2023-07-10